![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
| Item Type: | Article |
|---|---|
| Title: | Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort |
| Creators Name: | Andersen, L.B., Dechend, R., Jørgensen, J.S., Luef, B.M., Nielsen, J., Barington, T. and Christesen, H.T. |
| Abstract: | OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio prospectively associate to preeclampsia (PE) and clinical subtypes. METHODS: In an unselected cohort of 1909 pregnant women, sFlt-1 and PlGF were measured with KRYPTOR assays in gestational weeks (GW) 8-14 and 20-34. Associations to PE were assessed by receiver operating characteristics and logistic regression. RESULTS: Concentrations of sFlt-1, PlGF, and sFlt-1/PlGF in GW20-34 were predictive of PE development, but not in GW8-14. PlGF outperformed sFlt-1/PlGF ratio with an area under curve (AUC) of 0.755 vs. 0.704, p = 0.002. The highest AUC values for PlGF and sFlt-1/PlGF ratio were seen for severe early-onset PE (0.901 and 0.883). Negative predictive values were high for all PE types, but positive predictive values were low. CONCLUSION: PlGF and sFlt-1/PlGF had good predictive value for PE at GW20-34 in a population-based unselected cohort, however with low positive predictive value. |
| Keywords: | PlGF, Prediction, Preeclampsia, Prenatal Screening, sFlt-1 |
| Source: | Hypertension in Pregnancy |
| ISSN: | 1064-1955 |
| Publisher: | Informa Healthcare |
| Volume: | 35 |
| Number: | 3 |
| Page Range: | 405-419 |
| Date: | August 2016 |
| Official Publication: | https://doi.org/10.3109/10641955.2016.1167219 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
